---
title: "Medicus Pharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284057186.md"
description: "Medicus Pharma has disclosed that it failed to meet Nasdaq's continued listing requirement due to its shares not maintaining a minimum bid price of $1.00 for 30 consecutive business days, violating Listing Rule 5550(a)(2). The company has until October 19, 2026, to regain compliance by achieving a bid price of $1.00 or more for at least 10 consecutive business days. There is no immediate impact on trading."
datetime: "2026-04-24T21:33:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284057186.md)
  - [en](https://longbridge.com/en/news/284057186.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284057186.md)
---

# Medicus Pharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard

On April 21, 2026, the company received notice from Nasdaq that its shares failed to maintain the $1.00 minimum bid price for 30 consecutive business days, violating Listing Rule 5550(a)(2). There is no immediate impact on trading, and the company has until October 19, 2026, to regain compliance by achieving a $1.00+ bid for at least 10 consecutive business days.

Original SEC Filing: Medicus Pharma Ltd. \[ MDCX \] - 8-K - Apr. 24, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [MDCX.US](https://longbridge.com/en/quote/MDCX.US.md)
- [MDCXW.US](https://longbridge.com/en/quote/MDCXW.US.md)

## Related News & Research

- [Medicus Pharma Upsizes ATM Program to $50 Million With Maxim Group and Yorkville Securities](https://longbridge.com/en/news/284057169.md)
- [Traws Pharma, Inc. 1Q 2026: Revenue $0 EPS $(0.53) — 10-Q Summary](https://longbridge.com/en/news/286555967.md)
- [HealthView CEO Steven Gonzalez Announces Inc. Articles on Why Presence Beats Certainty — and Why It Matters Even More in the Age of AI](https://longbridge.com/en/news/286959260.md)
- [While Everyone Chases AI, Pharma Keeps Getting Cheaper](https://longbridge.com/en/news/286650835.md)
- [Quad Announces Participation in the Rosenblatt Virtual Technology Summit: The Age of AI | QUAD Stock News](https://longbridge.com/en/news/286963031.md)